rfhg_229717.1

Basic information about the TSS

---

TSS ID: rfhg_229717.1 Species: human Chr: chr22		Start: 36301025 End: 36301046 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: D11393:67 GeneID: 4627 HGNC/MGI_ID: HGNC:7579 UniProt_ID: Q99529 Nearer transcript ids and distances:

Gene_name: myosin heavy chain 9 Gene_symbol: MYH9 Gene_synonyms: EPSTS FTNS MHA NMHC-II-A NMMHCA Gene_source: HGNC:7579

TATA-Box annotation

---

Distance to TSS:	678
Nearest PromoterID:	ENST00000495928.1
Entrez ID:	ENSG00000100345
Nearest Unigene:	ENST00000401701
Nearest Refseq:
Nearest Ensembl:
Gene Name:	myosin heavy chain 9
Gene Alias:
Gene Type:	protein_coding
CpG%:	0.000000
GC%:	0.523810
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MYH9 p2@MYH9 p3@MYH9 p5@MYH9 p8@MYH9
Sample		p1@MYH9	p2@MYH9	p3@MYH9	p5@MYH9	p8@MYH9
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	106.95	11.10	0.00	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	110.67	9.31	0.20	1.21	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	108.03	8.87	0.19	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	90.44	8.11	0.42	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	103.93	9.90	0.22	0.67	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	90.70	9.88	0.19	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	111.34	12.86	0.87	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	102.94	10.42	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	91.68	13.68	0.43	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	74.77	13.33	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	59.83	10.51	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	66.27	10.16	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	648.32	92.04	2.58	1.13	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	605.61	88.11	4.36	1.20	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	552.84	75.31	3.29	1.98	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	560.32	77.21	3.27	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	536.84	63.77	1.97	1.31	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	539.93	65.80	2.11	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	512.89	46.38	2.67	0.00	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	529.86	75.22	5.42	1.20	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	636.32	95.03	4.81	0.67	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	573.28	87.52	3.45	1.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	607.25	85.57	4.27	1.42	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	547.22	82.02	2.67	2.43	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	616.08	76.88	2.58	2.06	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	579.85	70.90	3.48	1.58	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	517.04	59.34	4.40	1.10	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	756.30	114.10	7.54	1.89	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	557.26	79.31	4.04	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	655.28	96.09	6.33	2.17	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	591.81	79.97	4.40	1.47	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	574.81	82.26	2.93	1.17	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	607.13	76.39	4.64	2.74	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	651.02	77.85	4.95	2.47	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	599.11	79.28	3.74	2.24	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	634.08	89.10	5.17	1.92	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	609.46	90.74	5.93	1.43	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	611.51	80.19	4.43	1.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	598.82	80.49	7.29	2.70	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	601.36	82.82	4.32	1.20	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	586.27	85.87	4.00	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	604.32	77.44	5.71	2.78	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	575.95	86.26	8.22	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	616.62	88.11	6.12	1.40	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	635.65	89.34	6.83	2.01	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	594.88	79.57	8.38	2.56	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	609.36	84.69	3.84	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	547.22	89.12	4.17	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	669.05	89.53	4.55	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	581.11	78.05	6.07	1.21	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	726.77	89.56	3.89	0.82	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	833.68	108.96	4.00	2.22	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1245.30	83.95	0.00	41.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	796.30	99.01	3.19	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	822.83	100.08	3.65	2.98	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	651.02	78.86	15.10	8.39	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	660.85	101.49	8.73	2.76	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	817.73	104.04	7.13	0.32	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	772.41	105.34	4.18	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	720.45	130.45	10.06	2.83	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	922.92	119.15	4.23	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	842.30	88.60	1.68	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	645.67	116.24	10.35	13.53	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	746.47	124.35	8.83	3.06	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	931.87	122.82	4.87	1.62	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	943.18	132.76	3.19	3.19	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1276.95	113.15	16.16	32.33	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1697.96	229.03	0.00	47.38	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	871.19	92.63	3.41	2.44	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	809.76	98.68	4.96	1.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	817.67	99.45	1.41	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	596.47	71.87	1.32	1.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	626.11	66.51	2.78	1.24	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	711.77	67.26	1.83	1.22	0.31
Adipocyte - breast, donor1	11376-118A8	416.87	28.98	2.06	0.79	0.32
Adipocyte - breast, donor2	11327-117E4	361.76	38.98	3.53	3.21	2.09
Adipocyte - omental, donor1	11473-119C6	620.23	48.09	10.18	0.51	0.64
Adipocyte - omental, donor2	11474-119C7	411.12	35.13	3.74	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	365.73	34.83	4.35	0.67	1.67
Adipocyte - perirenal, donor1	11476-119C9	329.20	20.42	5.10	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	202.31	13.19	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	144.07	14.90	3.61	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	40.32	13.38	0.17	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	252.68	37.35	1.37	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	178.88	30.89	0.51	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	206.57	29.27	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	119.91	18.22	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	70.94	14.64	0.32	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	93.92	15.81	0.97	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	87.44	10.66	0.53	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	65.10	6.68	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	73.61	10.40	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	81.38	12.56	1.00	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	97.52	10.80	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	47.19	3.65	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	764.87	118.01	1.10	1.10	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	793.90	79.96	0.36	4.66	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	363.00	45.52	1.20	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	487.54	41.56	0.36	1.44	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	197.47	30.12	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	514.03	47.05	1.64	1.64	1.23
Anulus Pulposus Cell, donor1	11248-116E6	302.43	29.06	0.34	0.92	0.92
Anulus Pulposus Cell, donor2	11463-119B5	257.89	24.00	0.24	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	526.57	30.10	0.90	1.35	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	529.22	36.90	0.87	2.60	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	387.38	40.66	2.14	0.00	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	463.93	32.58	0.60	2.69	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	479.30	32.88	1.26	5.06	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	327.39	26.40	0.66	1.98	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	453.87	29.24	0.65	3.57	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	500.49	34.95	0.49	3.40	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	386.02	23.76	1.19	4.75	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	496.41	36.16	1.13	4.52	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	503.62	29.03	0.73	5.08	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	282.10	42.63	2.51	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	527.65	41.84	0.16	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	517.26	23.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	349.99	28.20	0.60	0.60	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	517.57	37.51	1.07	2.14	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	486.89	53.47	0.57	1.32	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	561.57	31.81	1.07	2.94	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	562.84	46.82	0.00	0.98	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	482.82	48.76	0.66	2.16	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	372.22	22.81	2.40	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	562.88	46.02	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	528.31	48.89	1.54	4.12	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	406.91	16.78	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	560.67	33.01	0.97	3.40	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	530.85	44.40	1.14	3.04	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	397.33	37.55	1.21	4.85	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	498.78	35.34	0.57	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	486.55	49.60	0.86	1.92	2.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	442.62	35.62	0.52	0.26	2.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	500.64	39.41	0.47	2.35	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	461.75	44.70	1.93	3.22	2.57
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	374.56	26.40	0.00	3.57	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	455.09	32.76	1.17	1.17	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	478.40	40.64	0.00	2.71	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	416.98	28.51	2.38	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	438.38	34.07	0.51	3.05	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	455.13	40.24	0.76	2.29	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	363.43	26.69	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	523.45	31.50	1.73	1.73	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	430.15	45.94	1.06	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	339.57	26.10	0.87	1.74	1.74
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	577.23	32.12	0.94	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	412.62	37.80	0.34	1.53	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	421.58	23.16	0.00	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	496.45	21.13	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	460.56	48.67	1.07	2.36	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	428.99	31.29	0.00	1.80	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	448.32	27.70	0.73	2.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	495.85	40.92	0.92	1.84	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	402.95	56.11	2.55	10.20	12.75
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	377.53	27.20	0.76	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	527.66	49.13	0.62	2.06	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	464.81	29.68	0.92	3.06	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	567.40	39.68	0.48	7.17	4.30
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	488.27	41.91	1.11	1.55	2.88
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	364.67	24.41	3.05	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	448.65	31.02	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	540.97	52.69	0.53	1.85	1.85
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	409.24	30.53	1.82	3.63	0.73
Astrocyte - cerebellum, donor1	11500-119F6	841.91	78.85	0.98	1.97	0.98
Astrocyte - cerebellum, donor2	11580-120F5	657.25	67.27	0.86	1.71	1.03
Astrocyte - cerebellum, donor3	11661-122F5	494.58	61.04	1.26	1.26	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	284.45	38.34	0.35	1.39	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	473.83	59.05	1.13	2.59	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	549.51	68.02	0.00	2.09	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	202.65	46.79	0.34	1.83	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	245.30	42.97	0.50	2.76	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	205.63	46.09	0.34	1.02	0.57
Basophils, donor1	12241-129G9	611.99	39.75	0.00	0.00	0.26
Basophils, donor2	12242-129H1	602.17	53.04	0.36	0.00	0.36
Basophils, donor3	12243-129H2	456.43	44.39	0.29	0.59	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	438.11	34.71	1.72	1.51	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	514.79	45.26	0.46	1.83	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	186.51	28.69	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	345.84	21.97	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	539.84	50.53	0.62	1.87	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	370.31	25.10	0.23	0.69	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	216.47	28.79	0.72	2.16	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	187.05	15.97	0.31	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	155.58	24.45	0.00	0.23	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	131.75	23.66	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	237.86	51.71	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	592.30	36.63	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	589.10	43.24	1.30	0.74	2.23
CD14+ Monocytes, donor3	11381-118B4	460.81	42.15	0.44	1.32	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	148.03	31.98	3.40	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	133.43	24.26	1.14	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	119.66	29.59	3.29	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	407.77	22.41	1.59	1.01	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	277.30	20.82	0.60	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	362.45	26.06	0.47	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	365.43	22.77	1.17	0.33	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	269.94	19.87	0.83	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	365.45	21.82	0.50	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	404.72	29.76	0.59	1.17	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	328.14	23.32	1.07	1.07	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	374.76	26.33	0.00	1.31	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	339.02	19.43	0.70	0.70	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	327.38	22.18	0.53	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	362.76	23.30	1.11	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	405.04	24.69	1.49	1.49	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	330.65	22.35	0.40	1.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	311.67	17.91	0.62	0.62	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	608.11	33.17	0.69	2.52	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	403.77	26.92	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	455.23	33.17	0.44	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	382.50	20.98	0.00	0.81	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	348.75	25.30	1.05	0.70	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	425.03	29.04	0.42	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	697.55	35.46	1.47	2.94	2.57
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	510.79	32.76	0.35	2.11	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	709.86	38.61	0.88	2.19	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	360.78	28.07	0.35	1.57	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	304.77	16.73	1.12	0.74	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	336.90	29.10	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	519.64	29.89	0.82	1.64	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	447.84	30.13	0.46	1.62	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	489.50	24.13	0.46	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	200.09	22.89	0.22	0.87	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	260.10	18.94	0.00	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	196.04	15.81	0.00	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	496.44	34.57	0.62	0.93	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	431.37	27.24	0.52	0.70	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	474.70	32.33	0.22	1.11	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	266.91	18.37	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	260.62	16.03	0.66	0.00	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	254.76	17.48	0.00	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	292.65	30.48	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	259.67	28.48	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	279.61	19.68	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	286.77	30.92	0.53	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	291.62	42.35	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	302.54	30.89	0.00	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	275.31	25.88	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	307.16	32.96	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	456.98	51.78	0.00	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	323.54	35.55	0.73	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	425.06	42.41	1.01	1.01	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	197.58	11.72	0.00	0.81	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	146.61	13.58	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	332.34	30.12	1.00	1.00	2.01
CD34+ Progenitors, donor2	11625-122B5	360.12	35.39	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	159.32	16.91	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	149.95	18.94	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	812.30	55.34	2.50	0.00	1.43
CD4+ T Cells, donor2	11306-117C1	744.63	65.52	3.67	4.90	5.51
CD4+ T Cells, donor3	11382-118B5	896.07	65.57	1.83	1.83	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	569.94	41.09	1.79	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	554.76	40.65	1.57	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	543.59	38.23	1.44	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	434.27	37.45	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	487.41	37.22	0.00	2.81	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	421.92	32.96	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	465.77	28.90	2.02	1.01	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	489.58	44.57	0.85	1.19	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	389.96	31.44	0.81	0.64	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	459.51	22.86	0.00	0.90	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	531.77	41.93	0.35	2.45	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	753.25	61.60	1.32	1.32	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	596.62	33.31	2.11	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	419.49	31.17	1.25	1.66	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	367.87	22.72	0.33	0.33	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	684.19	42.15	0.82	0.82	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	778.73	44.48	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	674.25	39.45	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	758.77	36.71	1.48	0.56	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	548.48	29.24	0.87	0.43	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	684.04	39.09	2.52	0.21	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	566.28	41.97	0.00	2.53	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	521.20	41.59	0.00	2.17	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	658.52	47.94	0.87	2.18	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	610.17	54.44	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	497.60	44.31	0.00	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	436.89	60.02	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	741.34	50.40	0.83	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	907.95	71.41	0.49	1.47	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	685.30	78.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	633.51	59.81	0.36	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	594.16	67.86	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	828.31	66.13	4.26	1.31	0.33
CD8+ T Cells, donor2	11307-117C2	744.11	56.69	1.50	3.00	2.63
CD8+ T Cells, donor3	11383-118B6	696.62	66.15	1.26	4.04	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	226.41	22.48	0.23	1.15	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	213.04	16.77	0.96	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	223.80	15.32	0.27	2.46	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	224.86	15.31	0.30	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	223.66	18.00	0.00	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	216.70	24.79	0.68	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	205.33	17.17	0.43	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	183.72	17.37	0.00	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	209.89	17.82	0.47	0.23	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	179.01	18.11	0.91	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	165.01	14.53	0.87	1.16	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	160.39	15.45	0.00	1.60	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	186.04	18.82	0.00	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	200.84	14.12	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	144.70	8.95	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	224.02	20.89	0.36	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	228.74	25.03	0.00	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	211.42	17.68	0.00	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	218.35	17.43	0.32	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	184.54	19.38	0.62	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	187.86	16.35	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	147.25	14.53	1.15	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	148.97	11.43	0.00	0.39	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	131.62	13.62	0.00	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	275.41	20.88	0.80	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	248.30	23.08	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	220.39	20.04	1.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	171.81	7.31	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	101.29	13.34	0.00	1.48	0.99
Cardiac Myocyte, donor3	11686-122I3	383.15	40.30	0.42	0.74	0.32
Chondrocyte - de diff, donor1	11261-116G1	382.03	25.31	3.47	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	445.29	41.93	2.84	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	199.34	19.34	2.16	1.02	0.34
Chondrocyte - re diff, donor2	11339-117F7	502.24	20.59	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	239.81	26.29	0.81	1.62	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	1008.27	102.82	2.07	1.72	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	952.33	113.72	0.64	3.42	4.70
Ciliary Epithelial Cells, donor3	11399-118D4	803.38	113.45	1.68	2.65	1.59
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	355.52	37.51	0.09	1.19	0.37
Corneal Epithelial Cells, donor1	11526-119I5	504.80	38.43	1.98	1.10	0.44
Corneal Epithelial Cells, donor2	11606-120I4	333.32	15.93	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	388.56	31.44	0.51	1.02	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	337.95	31.37	0.17	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	356.73	32.80	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	282.96	10.35	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	275.59	34.12	1.08	1.62	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	276.05	28.01	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	287.26	45.05	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	301.98	30.00	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	871.20	83.72	1.00	0.83	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	438.91	37.55	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	654.39	64.48	1.70	0.85	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	601.18	57.01	0.39	0.39	1.18
Endothelial Cells - Artery, donor1	11264-116G4	555.57	70.68	4.36	0.87	1.45
Endothelial Cells - Artery, donor2	11341-117F9	651.96	67.05	4.71	4.24	2.35
Endothelial Cells - Artery, donor3	11413-118E9	692.65	75.03	1.23	1.23	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	642.79	73.59	0.44	0.44	2.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	674.86	87.93	1.52	0.91	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	740.28	91.34	4.51	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	838.21	52.89	9.21	1.49	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	356.13	30.72	1.04	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	557.79	63.10	4.40	3.12	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	712.61	42.41	6.80	1.60	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	745.31	71.81	2.10	2.10	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	590.17	55.17	3.11	0.62	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	284.61	33.46	0.22	0.22	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	293.35	33.95	0.61	0.85	1.10
Endothelial Cells - Vein, donor1	11267-116G7	383.34	44.36	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	654.50	65.66	1.40	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	464.43	48.04	0.79	0.94	0.79
Eosinophils, donor1	12244-129H3	762.35	76.23	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	2051.28	122.12	0.00	1.65	0.00
Eosinophils, donor3	12246-129H5	1540.87	124.84	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	452.49	54.97	1.47	1.22	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	316.19	22.88	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	325.38	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	622.34	46.39	2.87	1.23	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	115.29	8.32	3.18	0.44	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	109.31	9.97	2.17	0.33	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	538.85	49.97	8.73	1.94	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	912.86	88.30	2.59	0.96	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	372.73	31.96	4.75	2.11	1.58
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	736.46	54.02	10.54	2.90	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	319.91	44.85	1.33	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	538.00	71.22	0.00	1.36	2.27
Fibroblast - Cardiac, donor2	11345-117G4	1144.50	92.47	0.76	3.03	1.52
Fibroblast - Cardiac, donor3	11417-118F4	640.01	69.55	6.31	3.00	2.52
Fibroblast - Cardiac, donor4	11452-119A3	202.17	22.73	2.12	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	329.32	28.55	0.76	1.14	0.38
Fibroblast - Cardiac, donor6	11460-119B2	309.55	30.17	0.45	0.76	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	597.33	48.24	2.41	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	260.58	28.04	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	376.45	49.80	0.00	5.86	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	377.09	50.28	0.46	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	158.24	25.27	0.34	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	144.16	17.14	3.05	0.47	0.23
Fibroblast - Dermal, donor2	11346-117G5	289.61	32.07	0.00	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	132.61	17.65	0.73	0.85	0.36
Fibroblast - Dermal, donor4	11450-119A1	224.40	24.98	0.23	0.68	0.79
Fibroblast - Dermal, donor5	11454-119A5	270.93	30.18	0.17	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	293.01	31.67	0.49	0.65	0.65
Fibroblast - Gingival, donor1	11237-116D4	268.20	26.45	0.83	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	403.48	40.61	2.36	0.79	1.57
Fibroblast - Gingival, donor2	11318-117D4	288.87	34.66	0.26	2.11	1.45
Fibroblast - Gingival, donor3	11394-118C8	255.25	26.98	1.84	0.48	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	649.31	51.94	7.27	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	560.68	50.57	2.64	3.17	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	314.75	38.82	0.16	0.47	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	356.05	37.73	0.27	1.35	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	489.09	54.34	1.76	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	390.62	33.93	1.17	0.44	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	369.24	27.68	0.82	0.82	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	388.75	32.58	0.88	0.44	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	320.92	35.07	1.32	0.44	0.44
Fibroblast - Lung, donor1	11270-116H1	373.82	42.14	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	376.02	35.81	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	239.74	26.38	0.42	1.69	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	793.04	50.81	4.17	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	246.16	18.18	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	264.20	19.87	1.12	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	595.56	64.55	4.47	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	295.57	35.95	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	542.02	23.83	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	321.80	34.33	0.39	0.97	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	305.34	38.68	0.30	1.21	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	325.57	28.46	0.92	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	479.70	55.72	1.53	2.29	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	618.82	59.40	1.89	2.70	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	491.50	54.28	1.28	0.35	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	312.81	35.26	0.22	0.66	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	749.16	70.10	1.22	0.20	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	296.01	36.75	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	188.98	20.16	0.40	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	2348.63	182.77	1.98	5.16	4.17
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	536.41	45.83	4.44	0.71	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	529.17	39.22	2.96	1.18	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1266.60	118.24	1.20	4.21	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	529.07	37.57	3.45	1.30	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	1695.60	114.14	0.51	3.04	2.02
Fibroblast - skin normal, donor1	11553-120C5	628.25	44.96	6.23	0.82	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1300.29	134.54	0.60	1.40	1.20
Fibroblast - skin normal, donor2	11561-120D4	711.98	50.73	5.02	1.51	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2108.41	199.78	1.81	4.53	4.23
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	538.17	38.77	2.57	1.08	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	301.56	20.69	3.42	1.03	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1443.46	132.36	2.30	3.94	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	771.43	61.25	3.73	1.81	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	754.17	61.57	1.35	2.53	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	183.95	19.45	3.14	1.41	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	220.50	16.56	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	631.02	51.66	2.95	1.56	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	735.70	82.50	3.38	2.08	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	587.17	66.18	1.53	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	99.52	13.78	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	81.67	14.04	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	107.26	30.81	0.29	0.86	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	104.79	26.75	1.38	0.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	92.93	21.46	1.37	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	114.72	24.17	0.40	0.59	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	101.24	27.76	0.53	0.53	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	86.43	17.29	0.65	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	86.23	17.25	0.44	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	109.67	22.33	0.57	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	130.28	21.80	0.25	0.49	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	90.80	18.80	1.07	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	315.31	54.02	1.36	1.36	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	360.60	60.63	0.97	1.52	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	226.28	41.88	0.20	1.42	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	265.14	48.15	0.23	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	394.13	61.91	1.00	1.00	1.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	363.49	80.00	2.40	0.66	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	150.99	25.41	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	253.38	34.81	0.79	0.48	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	177.84	34.85	0.45	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	153.04	28.43	1.01	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	182.53	23.24	0.51	1.02	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	315.41	38.93	0.80	0.09	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	224.14	31.01	1.46	0.73	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	205.61	26.47	1.37	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	167.86	25.67	0.33	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	205.99	25.46	0.33	0.08	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	206.84	25.93	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	166.69	26.41	0.21	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	184.01	25.25	0.69	0.69	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	145.92	27.52	0.67	0.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	144.60	22.48	1.32	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	168.01	24.11	0.61	0.74	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	123.19	21.72	0.32	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	130.21	17.96	0.64	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	166.67	24.92	0.47	0.57	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	125.59	25.62	0.63	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	156.61	20.37	0.91	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	173.01	27.18	0.84	0.73	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	130.85	21.96	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	127.09	23.29	0.28	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	256.74	27.22	1.20	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	139.32	18.72	1.07	0.80	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	188.96	26.93	0.61	0.31	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	225.78	27.59	0.52	1.55	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	150.45	23.04	0.54	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	251.82	29.68	1.29	1.47	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	315.81	38.38	1.75	1.75	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	183.47	26.78	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	444.41	47.75	1.06	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	402.10	47.61	0.61	1.61	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	287.45	39.65	1.27	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	143.72	26.87	0.20	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	109.09	21.57	0.46	0.46	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	130.73	23.32	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	82.61	14.71	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	65.84	13.85	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	78.87	11.99	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	79.19	27.22	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	87.81	17.41	0.39	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	121.94	17.65	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	97.37	26.08	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	72.91	12.37	0.98	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	86.89	20.18	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	76.62	12.58	0.84	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	81.38	15.69	0.33	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	96.47	15.94	1.68	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	94.15	19.40	0.64	0.95	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	90.01	16.64	0.68	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	81.44	10.44	4.18	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	107.67	23.48	0.00	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	90.57	18.35	0.30	0.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	86.40	20.33	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	107.69	17.40	0.41	0.41	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	89.98	17.03	0.92	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	126.44	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	91.11	12.30	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	72.69	12.06	1.30	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	58.86	11.37	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	86.69	15.03	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	160.90	23.28	0.68	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	86.97	7.45	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	73.14	14.63	1.42	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	96.56	15.09	0.00	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	94.10	15.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	88.94	16.35	0.00	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	100.64	13.32	1.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	145.19	18.89	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	92.18	16.92	0.58	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	100.50	21.94	0.44	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	95.79	12.72	0.00	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	92.52	13.13	0.00	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	92.20	15.04	0.00	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	631.14	43.37	2.28	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	605.43	65.70	2.08	4.99	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	526.24	59.60	2.25	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	233.75	24.74	0.00	3.17	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	148.72	20.89	0.00	2.09	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	152.71	14.39	0.12	1.04	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	166.10	13.50	0.17	1.35	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	153.11	14.56	0.46	0.91	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	148.88	12.79	0.22	1.53	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	163.76	15.04	0.86	0.86	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	151.13	12.49	0.00	1.08	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	113.08	8.34	0.00	1.25	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	114.60	8.41	0.17	0.51	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	103.16	10.25	0.00	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	527.16	51.49	6.16	1.12	3.92
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	700.26	77.47	6.49	3.90	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	314.61	26.44	2.64	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	795.03	77.25	2.82	1.76	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	706.90	67.57	2.18	3.63	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	207.36	25.35	0.00	2.10	1.40
Hepatocyte, donor1	11523-119I2	185.22	6.05	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	134.67	9.70	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	162.59	19.02	1.23	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	197.11	25.45	0.00	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	200.13	16.43	1.75	0.35	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	360.72	38.42	1.37	0.41	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	114.62	15.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	49.84	19.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	61.51	10.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	18.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	68.22	17.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	65.02	5.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	10.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	56.91	9.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	59.87	11.09	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.17	8.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	49.49	6.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	67.83	14.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	80.50	16.10	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	81.49	15.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	97.82	15.11	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	73.94	12.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	71.09	17.54	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	47.68	7.55	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	57.14	9.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	85.01	15.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	100.37	13.98	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	104.58	12.12	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	74.73	25.52	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	102.11	7.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	96.23	19.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	67.29	9.26	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	96.58	15.80	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	66.01	15.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	107.79	11.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	79.67	11.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	61.60	12.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	74.99	15.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	69.74	18.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	10.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	78.94	8.53	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	56.80	12.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	17.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	61.67	7.36	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	72.61	18.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	31.04	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	82.47	8.46	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	805.96	66.50	10.53	1.63	0.82
Keratinocyte - epidermal, donor2	11349-117G8	474.36	42.75	1.76	0.59	1.76
Keratinocyte - epidermal, donor3	11421-118F8	410.62	36.92	0.85	1.51	1.89
Keratinocyte - oral, donor1	11251-116E9	669.75	65.61	1.02	2.95	0.68
Keratocytes, donor1	11527-119I6	548.07	59.83	0.69	0.69	0.69
Keratocytes, donor2	11607-120I5	191.00	16.41	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	289.08	39.52	0.00	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	362.66	50.55	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	433.66	57.17	0.00	3.24	2.16
Lens Epithelial Cells, donor2	11609-120I7	373.10	46.94	0.12	1.04	0.35
Lens Epithelial Cells, donor3	11690-122I7	782.96	70.33	0.10	0.81	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	554.47	67.83	2.02	1.90	1.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	294.14	23.44	1.40	0.28	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	400.46	37.46	2.20	3.31	2.20
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	368.33	37.10	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	411.61	28.05	0.63	1.26	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	346.52	33.75	0.65	2.48	2.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	356.63	36.94	2.46	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	330.44	25.79	1.26	1.01	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	376.09	38.57	1.41	3.52	3.24
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	332.25	24.92	0.40	1.58	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	280.55	21.33	1.74	1.74	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	352.15	32.22	0.19	1.67	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	367.59	26.83	0.70	2.09	2.44
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	332.02	24.81	1.43	0.48	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	354.77	32.41	1.10	4.26	3.02
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	327.98	32.64	0.31	2.77	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	282.44	21.82	1.25	0.62	1.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	445.22	39.34	1.46	2.56	2.01
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	363.34	33.90	0.00	2.30	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	338.85	15.82	0.29	1.76	3.22
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	448.82	41.07	2.99	2.99	1.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	333.65	23.76	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	266.60	17.23	1.62	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	409.33	36.18	1.82	2.88	1.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	352.00	24.37	0.00	2.07	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	289.80	16.12	1.05	1.26	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	385.10	39.70	0.75	2.71	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	332.93	32.33	0.69	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	277.90	17.69	1.13	1.13	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	376.62	36.05	1.91	3.18	2.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	328.06	24.23	0.48	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	248.09	14.55	0.99	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	385.30	36.67	2.35	2.60	2.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	395.01	34.43	2.59	1.85	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	239.92	15.81	0.25	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	347.86	34.51	1.10	1.79	1.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	375.03	38.92	0.96	1.61	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	301.89	19.48	2.74	1.52	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	363.35	35.27	1.26	2.80	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	332.45	35.56	0.71	1.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	274.38	10.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	377.97	34.08	1.24	3.42	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	295.80	27.93	1.07	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	294.99	15.68	0.98	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	341.36	29.43	1.41	2.83	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	511.59	55.19	2.23	1.61	1.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	273.03	13.06	0.77	2.05	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	302.24	26.85	2.09	3.28	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	83.84	20.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	107.40	13.81	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	99.46	11.13	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	136.67	13.54	0.85	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	92.84	11.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	81.26	10.27	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	137.58	10.31	1.03	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	92.78	22.60	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	128.70	14.02	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	100.92	10.76	0.58	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	77.88	14.41	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	188.33	19.78	0.54	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	120.68	20.03	0.00	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	103.03	18.70	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	67.30	11.99	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	113.59	19.87	0.00	1.53	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	97.12	15.47	0.00	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	105.05	19.84	0.57	0.76	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	125.17	12.27	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	124.76	16.31	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	106.83	18.53	0.42	0.62	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	106.78	8.69	0.28	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	126.73	24.73	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	102.48	20.32	0.00	2.32	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	95.36	11.96	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	89.63	17.70	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	140.69	22.98	0.35	1.41	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	106.21	11.43	0.37	1.84	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	103.61	11.51	1.15	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	124.72	21.11	0.00	1.15	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	116.62	15.85	0.00	3.40	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	102.56	11.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	119.75	22.59	0.45	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	125.68	16.52	0.72	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	91.87	17.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	154.95	20.07	1.11	2.23	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	109.84	13.78	0.00	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	115.60	23.98	0.00	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	122.94	15.99	0.33	1.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	145.40	16.89	0.00	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	125.14	21.33	0.71	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	128.21	19.25	0.34	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	133.65	16.64	0.00	0.54	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	118.51	20.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	124.09	21.48	0.74	1.85	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	101.17	16.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	98.37	14.81	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	135.25	18.81	0.00	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	134.47	22.53	0.73	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	137.21	23.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	119.37	21.70	0.99	0.99	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	150.55	18.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	133.25	25.14	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	143.30	19.38	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	163.50	17.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	151.42	34.74	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	152.89	29.72	0.39	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	150.42	17.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	149.45	32.69	0.00	1.04	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	199.97	28.44	0.88	1.31	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	166.61	21.80	0.00	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	151.48	32.24	0.88	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	154.29	23.14	0.00	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	163.05	19.24	0.00	2.53	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	160.05	32.68	0.96	1.92	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	144.71	26.64	0.40	1.19	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	164.06	18.23	0.61	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	139.03	13.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	147.82	36.48	0.76	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	162.15	25.82	0.52	0.52	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	152.98	15.12	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	147.04	25.04	0.32	0.95	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	160.99	25.06	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	131.60	18.39	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	175.87	26.74	0.51	1.54	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	173.30	21.93	0.71	1.41	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	149.82	22.70	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	148.10	29.95	0.00	2.08	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	184.80	21.14	1.57	3.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	139.04	17.95	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	135.21	23.70	0.46	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	164.59	18.73	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	174.83	22.99	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	172.95	32.33	0.40	2.02	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	150.51	27.53	0.00	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	201.83	22.23	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	171.53	30.77	1.71	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	184.06	29.91	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	135.15	17.51	1.09	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	163.92	26.73	0.00	0.00	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	250.86	31.45	0.78	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	173.07	19.23	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	162.13	22.86	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	160.45	29.63	0.23	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	209.20	39.09	0.55	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	205.14	38.41	0.66	0.26	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	352.60	43.54	0.53	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	1041.03	121.37	6.65	4.75	2.69
Mallassez-derived cells, donor3	11930-125I4	686.60	93.96	3.47	2.92	1.53
Mammary Epithelial Cell, donor1	11273-116H4	420.40	33.58	0.80	1.40	0.80
Mammary Epithelial Cell, donor2	11350-117G9	452.28	42.27	0.87	2.03	0.87
Mammary Epithelial Cell, donor3	11422-118F9	583.66	73.08	0.00	1.25	1.50
Mast cell - stimulated, donor1	11487-119E2	177.62	32.54	0.00	0.68	0.00
Mast cell, donor1	11563-120D6	250.99	50.29	2.16	0.65	0.22
Mast cell, donor2	11565-120D8	165.53	65.68	4.16	0.59	0.30
Mast cell, donor3	11566-120D9	208.02	71.81	4.73	0.45	0.00
Mast cell, donor4	11567-120E1	187.04	67.02	3.55	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	170.89	44.14	1.77	0.44	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	193.78	30.35	3.50	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	174.95	39.35	1.61	0.11	0.23
Mast cell, expanded, donor8	11941-126A6	314.65	30.96	7.87	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	221.48	28.56	0.20	0.30	0.40
Melanocyte - dark, donor2	11582-120F7	98.98	13.15	0.00	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	185.09	30.28	0.43	0.51	0.22
Melanocyte - light, donor1	11274-116H5	156.79	17.40	2.82	0.00	0.00
Melanocyte - light, donor2	11351-117H1	294.83	27.98	2.73	0.68	1.36
Melanocyte - light, donor3	11423-118G1	183.85	25.15	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	185.76	22.07	0.62	0.62	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	174.81	9.68	0.27	0.54	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	135.00	16.87	0.00	0.54	0.27
Meningeal Cells, donor1	11493-119E8	841.50	78.16	1.49	0.62	0.50
Meningeal Cells, donor2	11573-120E7	419.46	60.30	1.32	0.44	0.44
Meningeal Cells, donor3	11654-122E7	396.18	42.54	0.16	0.82	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	180.22	27.37	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	546.43	42.77	1.61	0.50	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	262.83	28.91	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	173.99	14.39	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	191.60	27.27	0.00	2.15	3.59
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	930.51	74.75	22.45	1.48	2.33
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	581.06	53.28	7.54	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	321.72	44.39	0.22	1.10	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	303.92	32.88	0.73	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	268.44	34.37	0.41	1.02	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	354.02	32.27	0.83	0.83	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	497.74	40.52	4.83	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	548.40	39.34	1.45	1.05	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	89.91	10.39	0.30	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	133.13	7.01	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	357.98	35.86	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	249.88	26.23	0.35	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	415.61	34.71	0.94	0.63	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	187.95	29.75	0.00	0.73	1.45
Mesothelial Cells, donor1	11247-116E5	701.12	85.92	3.98	1.33	1.06
Mesothelial Cells, donor2	12156-128G5	644.10	89.08	1.50	1.50	1.00
Mesothelial Cells, donor3	11402-118D7	768.53	116.85	6.65	3.18	2.38
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	114.78	35.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	139.15	23.89	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	155.18	27.97	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	141.74	41.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	103.21	21.39	0.62	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	120.73	27.59	1.04	0.00	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	106.54	11.58	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	103.61	24.78	1.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	165.25	30.72	0.47	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	112.58	24.39	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	140.96	32.07	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	128.27	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	95.57	21.24	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	166.79	24.32	0.76	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	139.49	22.37	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	108.87	23.13	0.42	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	94.84	11.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	120.12	17.59	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	73.77	11.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	111.90	20.57	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	127.63	23.29	0.48	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	144.86	18.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	118.58	18.19	0.46	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	167.43	29.45	0.63	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	137.99	27.72	0.82	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	100.83	18.66	0.64	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	125.59	20.90	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	41.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	109.29	24.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	112.54	20.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	145.82	21.54	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	94.86	19.57	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	158.51	30.58	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	89.41	9.81	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	102.84	21.62	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	163.29	20.81	2.80	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	95.99	17.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	122.14	20.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	53.00	12.23	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	95.47	13.14	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	103.74	25.38	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	78.13	17.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	115.28	20.58	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	77.24	17.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	97.23	26.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	132.31	21.88	0.34	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	102.40	16.19	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	115.05	17.04	0.71	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	157.39	28.90	0.00	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	117.21	19.53	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	87.41	22.73	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	158.07	27.45	0.90	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	129.81	23.79	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	79.41	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	130.22	20.32	0.00	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	126.34	21.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	127.13	22.66	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	121.54	22.55	1.04	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	102.53	18.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	85.75	17.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	107.82	19.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	141.58	25.44	1.20	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	117.38	18.36	0.14	0.28	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	117.85	20.38	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	113.22	20.57	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	102.38	20.10	0.00	0.00	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	116.20	24.15	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	146.01	25.07	0.49	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	102.31	16.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	138.78	21.17	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	136.09	25.37	0.58	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	187.53	32.56	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	142.94	25.01	0.60	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	19.60	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	114.01	27.27	0.66	1.31	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	91.52	22.09	0.00	1.05	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	96.67	24.12	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	98.72	27.94	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	119.04	23.28	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	120.39	24.77	0.00	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	102.81	19.68	0.00	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	81.04	14.00	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	106.63	21.25	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	118.23	24.89	0.00	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.57	2.14	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	11.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	91.90	13.13	0.00	1.01	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	2.53	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	3.18	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	1.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	22.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	143.55	13.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	95.05	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	851.62	91.56	4.09	3.23	2.37
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	725.39	74.21	10.45	3.14	3.14
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	158.86	17.35	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	124.38	15.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	183.68	30.80	0.38	0.57	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	339.92	52.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	104.71	13.60	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	191.11	18.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	152.35	17.16	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	183.39	19.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	192.13	23.51	1.08	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	276.25	29.22	1.05	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	311.77	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	215.91	22.83	0.50	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	152.12	18.41	1.89	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	160.94	19.95	1.13	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	214.42	27.27	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	282.86	24.97	0.55	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	173.98	18.03	0.53	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	175.89	21.61	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	122.74	14.44	2.63	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	177.42	22.93	1.30	0.16	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	285.92	29.63	0.18	0.35	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	170.18	21.80	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	185.26	18.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	223.98	27.31	1.29	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	193.48	26.56	2.07	0.34	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	293.30	32.87	0.00	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	247.96	27.18	0.00	0.00	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	198.99	21.59	1.27	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	157.60	19.23	0.47	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	305.63	36.49	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	117.36	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	216.93	23.66	1.33	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	311.55	38.77	0.00	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	225.78	21.43	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	152.30	16.72	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	253.13	32.54	1.14	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	223.56	30.96	0.98	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	122.46	16.56	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	408.87	52.92	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	239.88	29.10	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	134.96	15.29	1.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	249.01	25.30	1.49	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	181.08	20.67	1.15	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	249.82	37.20	1.51	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	458.85	50.39	0.66	0.44	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	216.85	18.30	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	153.29	10.22	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	233.51	32.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	186.95	22.35	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	95.64	13.92	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	350.47	35.60	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	158.71	15.87	5.67	3.40	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	131.51	15.17	0.00	10.12	5.06
Myoblast, donor1	11241-116D8	278.40	20.00	0.50	0.25	0.87
Myoblast, donor2	11322-117D8	219.02	27.04	0.77	0.96	0.58
Myoblast, donor3	11398-118D3	361.21	49.94	1.35	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	205.62	31.23	0.58	0.58	0.15
Natural Killer Cells, donor1	11230-116C6	671.92	49.20	2.77	1.85	0.62
Natural Killer Cells, donor2	11311-117C6	588.94	60.01	0.60	3.32	2.71
Natural Killer Cells, donor3	11387-118C1	528.23	60.19	1.10	1.29	0.55
Neural stem cells, donor1	11275-116H6	138.28	18.51	0.73	0.36	0.00
Neural stem cells, donor2	11352-117H2	132.87	21.18	0.00	0.00	0.00
Neurons, donor1	11494-119E9	61.45	7.97	0.00	0.00	0.00
Neurons, donor2	11574-120E8	87.85	17.17	0.00	0.00	0.22
Neurons, donor3	11655-122E8	55.09	11.51	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	1482.95	79.81	4.64	5.57	5.57
Neutrophils, donor2	11314-117C9	1524.81	130.45	11.60	28.99	8.70
Neutrophils, donor3	11390-118C4	2152.61	188.14	4.89	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	272.26	32.65	0.47	1.42	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	174.52	21.16	0.65	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	232.64	24.47	0.20	1.20	0.60
Olfactory epithelial cells, donor1	11933-125I7	686.06	63.04	1.38	3.72	5.64
Olfactory epithelial cells, donor2	11934-125I8	612.13	51.24	1.30	7.67	8.25
Olfactory epithelial cells, donor3	11935-125I9	472.63	42.68	0.79	3.29	1.25
Olfactory epithelial cells, donor4	11936-126A1	715.38	67.98	0.78	1.36	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	604.23	87.26	1.81	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	457.29	40.84	4.25	0.85	0.64
Osteoblast - differentiated, donor2	11353-117H3	153.18	14.86	3.43	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	142.14	16.76	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	977.58	83.65	0.98	0.78	0.39
Osteoblast, donor2	11354-117H4	793.62	94.81	2.11	0.70	0.70
Osteoblast, donor3	11426-118G4	694.57	86.02	0.71	1.78	2.67
Pancreatic stromal cells, donor1	11249-116E7	320.85	30.41	4.63	0.76	0.51
Pericytes, donor1	11491-119E6	626.43	48.62	5.90	1.00	0.45
Pericytes, donor2	11571-120E5	249.23	26.48	2.26	1.58	0.45
Pericytes, donor3	11652-122E5	518.19	55.13	2.64	2.24	2.03
Perineurial Cells, donor1	11499-119F5	359.63	51.42	0.45	0.57	0.57
Perineurial Cells, donor2	11579-120F4	141.33	18.22	0.09	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	708.56	54.82	2.87	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	476.26	37.22	0.98	1.47	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	536.17	45.68	1.16	1.16	0.65
Placental Epithelial Cells, donor1	11278-116H9	177.70	11.48	0.24	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	252.83	23.29	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	168.45	15.51	0.79	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	141.45	14.56	1.90	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	381.93	22.32	4.88	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	1854.79	170.47	0.91	0.91	1.57
Preadipocyte - breast, donor2	11328-117E5	511.31	39.18	2.93	1.58	0.90
Preadipocyte - omental, donor1	11468-119C1	389.68	30.58	7.46	1.07	0.21
Preadipocyte - omental, donor2	11329-117E6	527.69	43.65	2.62	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	565.69	60.59	10.31	1.86	2.72
Preadipocyte - perirenal, donor1	11469-119C2	336.62	30.51	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	612.09	41.77	1.23	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	368.85	35.77	0.53	1.77	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	254.41	27.25	1.70	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	373.43	31.58	1.86	0.93	0.00
Preadipocyte - visceral, donor2	11357-117H7	273.81	28.99	4.14	3.68	0.46
Preadipocyte - visceral, donor3	11429-118G7	246.70	21.32	0.52	1.46	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	185.70	17.65	5.88	0.30	0.45
Prostate Epithelial Cells, donor2	11331-117E8	614.78	76.10	10.97	4.20	2.17
Prostate Epithelial Cells, donor3	11404-118D9	216.29	21.62	4.47	1.41	0.86
Prostate Stromal Cells, donor1	11254-116F3	413.91	36.68	5.58	1.25	1.14
Prostate Stromal Cells, donor2	11332-117E9	291.90	26.36	2.33	2.15	1.61
Prostate Stromal Cells, donor3	11405-118E1	242.86	27.22	3.13	1.77	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	722.30	71.90	3.28	1.82	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	539.31	46.92	0.76	1.59	1.04
Renal Epithelial Cells, donor1	11517-119H5	828.82	87.75	0.51	1.52	2.54
Renal Epithelial Cells, donor2	11597-120H4	689.27	58.33	2.13	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	737.88	64.37	1.59	1.91	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	550.13	65.36	2.72	0.68	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	432.05	34.90	1.35	0.67	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	529.72	53.06	1.11	5.11	4.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	575.61	51.90	3.33	2.00	2.66
Renal Mesangial Cells, donor1	11518-119H6	1053.12	92.00	6.38	0.88	1.32
Renal Mesangial Cells, donor2	11598-120H5	1094.72	85.27	4.39	3.13	2.51
Renal Mesangial Cells, donor3	11679-122H5	764.27	76.01	4.44	3.33	2.22
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	691.46	45.36	1.34	0.54	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	304.46	30.78	1.69	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	781.22	72.12	1.74	2.12	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	195.50	25.41	0.00	0.52	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	874.34	93.23	5.12	1.71	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	313.88	33.96	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	466.69	38.39	1.76	1.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	320.86	36.62	0.67	0.67	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	183.15	9.83	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	137.04	11.01	1.65	1.10	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	138.63	15.66	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	355.49	28.09	1.30	0.78	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	286.69	25.72	0.60	0.70	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	340.53	31.45	0.89	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	420.13	46.76	0.25	2.36	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	317.24	28.90	1.17	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	309.72	31.43	0.23	1.16	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	281.89	26.83	0.55	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	291.05	29.04	0.30	1.51	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	339.74	35.48	0.18	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	297.53	29.84	0.43	2.01	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	292.43	31.87	0.43	1.61	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	286.10	29.43	0.44	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	256.18	23.71	0.57	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	287.22	28.41	0.09	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	357.96	29.31	0.75	0.94	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	288.11	27.60	0.13	0.13	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	296.40	31.83	0.49	1.07	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	300.38	29.41	0.19	0.95	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	307.89	29.90	0.32	0.75	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	280.87	26.07	0.00	1.40	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	300.61	34.18	0.68	0.85	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	288.45	25.53	0.18	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	294.56	27.84	0.49	0.49	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	328.55	34.92	0.27	1.07	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	341.07	27.83	0.71	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	288.10	30.56	0.79	0.40	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	329.96	35.78	0.47	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	292.16	24.05	0.41	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	345.09	30.08	0.22	1.99	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	284.71	30.71	0.42	0.84	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	326.37	27.32	0.67	1.08	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	281.67	28.10	0.17	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	280.52	24.87	0.19	0.77	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	323.24	29.06	1.03	1.03	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	276.26	27.30	0.27	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	298.30	28.73	0.16	0.99	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	234.68	22.50	0.68	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	289.11	31.51	0.15	1.33	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	234.03	29.59	0.27	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	169.38	19.36	1.38	0.41	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	181.20	21.91	0.24	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	212.22	26.20	0.60	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	207.65	17.33	1.79	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	222.54	28.65	0.70	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	185.86	16.62	0.91	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	223.72	22.76	2.94	0.86	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	494.15	36.24	1.02	0.73	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	264.67	38.94	0.61	0.00	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	192.90	17.18	1.21	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	300.60	26.46	3.17	1.81	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	304.33	29.06	1.80	1.20	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	313.72	20.78	6.49	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	304.16	25.61	4.91	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	288.47	30.05	3.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	561.39	61.12	0.38	1.32	1.69
Schwann Cells, donor2	11578-120F3	214.35	44.23	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	534.12	73.83	1.10	4.82	5.48
Sebocyte, donor1	11220-116B5	1309.72	123.25	14.24	1.64	1.10
Sebocyte, donor2	11301-117B5	562.49	61.58	5.06	3.68	3.68
Sebocyte, donor3	11378-118B1	296.39	37.51	2.27	1.65	1.24
Sertoli Cells, donor1	11255-116F4	675.89	64.61	8.28	1.66	3.31
Sertoli Cells, donor2	11333-117F1	395.41	42.37	5.65	5.65	2.82
Skeletal Muscle Cells, donor1	11281-116I3	339.15	36.51	4.57	0.53	0.44
Skeletal Muscle Cells, donor2	11358-117H8	139.51	15.90	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	642.91	71.90	0.00	5.02	2.51
Skeletal Muscle Cells, donor4	11451-119A2	180.81	20.74	0.16	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	176.74	22.30	0.30	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	286.10	29.70	0.15	0.77	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	302.41	35.03	2.27	0.38	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	240.57	37.53	1.00	1.00	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	274.91	37.40	0.99	0.89	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	499.61	42.21	6.91	0.84	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	392.28	51.39	1.45	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	238.60	23.25	0.41	1.24	1.10
Skin - palm, donor1	10286-104F7	244.44	5.37	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	256.17	36.76	2.74	0.58	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	956.93	134.13	4.09	1.64	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	247.97	28.69	2.34	0.78	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	486.25	33.08	7.78	1.39	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	433.51	61.61	3.38	2.25	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1291.93	210.18	0.42	1.27	1.48
Small Airway Epithelial Cells, donor3	11406-118E2	311.72	39.65	1.95	0.60	1.50
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	145.34	12.65	1.54	0.00	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	702.12	53.14	6.23	1.78	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	432.64	38.80	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	421.65	28.07	2.21	0.66	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	593.82	39.77	1.18	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	471.27	36.31	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	76.06	11.01	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	803.92	69.07	4.26	0.93	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	299.68	31.70	0.66	1.99	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	287.04	29.83	0.51	0.77	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	326.89	32.88	0.00	0.65	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	629.93	74.13	0.89	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	513.51	57.23	1.14	1.57	0.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	412.87	40.99	0.81	0.65	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	258.16	28.92	0.61	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	294.99	36.37	0.76	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	342.76	73.45	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	450.13	32.42	0.48	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	338.16	27.28	0.74	0.88	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	266.25	26.69	0.43	0.86	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	260.61	27.50	0.94	0.63	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	614.38	50.43	1.08	0.77	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	489.36	29.10	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	376.56	28.39	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	500.49	46.09	0.68	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	361.78	32.98	0.55	1.18	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	355.87	33.61	10.47	1.21	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	240.30	19.80	2.96	1.14	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	684.72	38.04	1.81	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	214.85	32.85	0.26	1.06	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	524.11	35.69	4.53	1.33	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	217.01	18.91	2.75	1.25	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	375.93	41.09	2.03	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	388.54	31.81	3.77	0.60	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	208.55	34.51	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1417.56	43.94	2.58	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	428.79	46.97	0.47	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	371.09	27.77	1.01	3.03	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	402.08	27.58	2.51	1.25	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	233.05	22.71	0.88	1.18	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	161.03	21.74	0.00	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	190.60	25.69	0.47	0.00	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1045.85	87.07	2.59	0.43	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	657.28	72.92	2.29	3.06	1.78
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	499.60	39.11	0.75	0.75	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	491.48	61.07	0.98	0.70	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	743.62	88.31	0.50	0.84	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	234.76	14.76	0.48	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	1005.07	82.45	2.94	1.22	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	640.09	45.52	7.07	0.88	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	216.80	34.52	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	207.97	18.08	1.55	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	231.13	15.34	1.85	0.26	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	151.75	11.90	5.95	1.12	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	352.87	28.75	1.44	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	331.59	19.59	0.00	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	425.38	33.08	1.18	3.54	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	141.20	12.70	1.27	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	188.88	21.56	3.59	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	173.89	15.88	1.25	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	159.51	17.42	0.92	0.00	0.92
Synoviocyte, donor1	11291-117A4	1098.46	71.03	12.62	2.86	2.02
Synoviocyte, donor2	11368-117I9	166.79	11.57	1.68	1.01	0.67
Synoviocyte, donor3	11440-118H9	133.82	12.96	1.79	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	309.09	37.16	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	134.78	13.87	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	202.37	26.86	0.46	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	457.85	37.49	2.15	0.50	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	322.78	28.22	0.77	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	354.48	29.21	1.72	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	325.03	31.74	0.98	0.62	0.49
Urethra, donor2	10319-105A4	230.20	17.98	0.00	3.60	0.00
Urothelial Cells, donor1	11520-119H8	707.99	79.43	3.45	1.33	0.80
Urothelial Cells, donor2	11600-120H7	490.29	37.25	3.20	0.40	1.60
Urothelial Cells, donor3	11681-122H7	396.75	34.38	1.15	0.46	0.23
Urothelial cells, donor0	11216-116B1	619.65	51.49	0.67	1.11	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	1419.20	98.77	0.89	3.56	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	1445.34	100.07	1.43	15.73	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	737.91	82.14	1.37	4.11	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	830.89	65.77	0.34	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	837.84	67.40	0.58	2.91	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1319.25	86.42	1.04	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	1226.17	93.61	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	690.15	77.60	0.00	8.22	4.56
Wilms' tumor cell line:G-401	10809-111A8	144.70	23.44	0.74	0.37	0.25
Wilms' tumor cell line:HFWT	10597-108E3	100.32	22.88	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	194.68	12.01	0.00	0.56	0.56
achilles tendon, donor2	10292-104G4	390.57	45.46	0.00	2.07	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	116.51	20.65	0.00	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	208.26	15.79	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	237.30	38.22	0.71	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	272.39	34.01	0.00	1.63	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	213.06	24.45	0.28	0.56	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	226.92	27.49	0.42	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	315.49	41.38	0.00	0.82	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	159.51	19.83	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	356.91	40.02	0.82	0.82	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	571.19	58.63	0.39	1.16	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	155.11	20.24	0.00	1.10	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	210.63	35.10	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	183.81	26.49	0.46	2.09	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	228.09	30.55	0.26	1.81	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	282.89	28.93	0.29	1.75	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	110.61	14.87	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	197.81	23.44	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	107.43	16.27	0.92	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	241.09	28.59	0.00	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	284.49	41.25	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	262.61	35.14	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	105.58	17.82	0.67	0.45	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	130.08	13.01	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	87.34	14.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	241.06	26.74	0.38	0.75	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	215.01	18.32	0.00	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	65.61	15.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	113.98	10.83	0.47	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	672.60	68.56	1.71	0.93	2.02
adipose, donor1	10184-103D4	123.15	22.87	1.17	1.17	1.76
adipose, donor2	10185-103D5	53.53	13.79	0.00	0.00	0.41
adipose, donor3	10186-103D6	118.99	20.15	1.36	0.54	0.27
adipose, donor4	10187-103D7	227.96	38.14	1.73	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	57.76	13.10	0.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	105.49	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	312.17	35.89	0.40	0.27	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	215.45	8.93	0.36	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	162.29	13.22	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	248.17	27.72	0.68	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	101.64	5.60	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	60.48	9.49	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	88.81	23.52	0.00	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	49.06	7.42	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	1600.41	108.74	9.30	2.55	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	169.00	18.97	0.22	0.66	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	104.55	11.69	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	924.18	117.09	1.37	5.49	3.92
appendix, adult	10189-103D9	363.28	32.60	0.78	0.78	3.49
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	55.37	5.50	0.34	0.34	0.00
artery, adult	10190-103E1	247.28	20.38	0.00	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	1752.02	177.46	4.64	1.88	2.32
b cell line:RPMI1788	10427-106D4	146.02	29.29	0.15	0.30	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	862.58	87.67	3.61	1.66	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	384.72	28.88	2.18	0.40	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	175.91	8.87	0.67	0.50	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	166.09	16.78	1.12	0.00	0.56
bladder, adult, pool1	10011-101C2	328.42	35.63	1.52	0.87	0.87
blood, adult, pool1	10053-101G8	434.07	48.72	2.21	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	590.02	40.25	0.00	0.00	0.86
bone marrow, adult	10192-103E3	292.87	22.27	1.35	0.67	1.35
brain, adult, donor1	10084-102B3	58.43	16.40	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	84.19	11.92	0.11	0.33	0.22
brain, fetal, pool1	10085-102B4	34.73	8.01	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	100.76	12.22	0.66	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	336.65	43.69	0.50	0.00	0.25
breast, adult, donor1	10080-102A8	260.12	37.25	1.26	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	104.04	24.52	0.25	0.38	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	242.43	30.30	0.00	0.93	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	225.38	32.69	0.92	2.53	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	76.50	7.50	0.24	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	61.59	8.93	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	136.83	8.53	0.00	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	93.80	11.09	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	123.77	21.29	0.27	0.80	0.53
caudate nucleus - adult, donor10196	10177-103C6	67.93	16.12	1.15	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	73.29	12.72	0.17	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	40.50	10.70	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	48.71	5.13	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	99.05	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	97.36	17.93	0.21	0.85	0.21
cerebellum, adult, pool1	10083-102B2	33.80	8.97	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	78.05	9.96	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	90.77	10.34	0.00	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	105.25	13.16	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	115.31	9.20	1.15	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	395.90	33.31	1.99	0.17	0.83
cervix, adult, pool1	10013-101C4	522.12	53.44	1.89	0.63	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	707.42	51.14	3.34	1.53	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	438.90	58.78	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	459.57	57.79	11.31	1.12	1.12
choriocarcinoma cell line:SCH	10785-110H2	240.63	42.51	0.49	1.11	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	92.97	20.63	0.24	0.47	0.71
chorionic membrane cells, donor1	12238-129G6	255.29	23.93	0.28	1.14	0.57
chorionic membrane cells, donor2	12239-129G7	626.22	75.67	3.78	1.29	0.60
chorionic membrane cells, donor3	12240-129G8	486.29	40.11	0.55	3.30	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	149.45	16.16	0.00	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	219.57	30.16	0.19	0.96	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	110.45	12.67	0.21	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	27.48	6.93	0.26	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	35.80	7.50	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	32.78	6.72	0.20	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	61.84	7.95	0.00	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	119.11	15.64	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	501.97	80.92	2.74	4.34	2.97
clear cell carcinoma cell line:TEN	10636-108I6	174.20	18.74	0.52	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	253.33	29.10	0.73	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	69.55	9.12	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	393.90	33.32	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	323.49	28.08	1.53	0.59	0.35
colon, fetal, donor1	10070-101I7	211.97	16.69	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	288.76	77.92	0.00	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	279.61	31.87	0.85	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	212.96	28.68	0.30	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	260.45	33.28	0.42	0.14	0.28
corpus callosum, adult, pool1	10042-101F6	149.81	29.30	0.11	0.00	0.00
cruciate ligament, donor2	10295-104G7	406.05	38.90	1.62	3.24	0.81
diaphragm, fetal, donor1	10069-101I6	150.08	22.47	0.80	0.80	0.00
diencephalon, adult	10193-103E4	33.36	6.96	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	115.26	16.99	0.00	0.92	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	271.06	18.21	0.00	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	81.36	9.63	0.24	0.00	0.24
ductus deferens, adult	10196-103E7	183.89	15.45	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	210.27	28.80	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	347.23	25.75	0.74	2.94	0.74
dura mater, adult, donor1	10041-101F5	588.19	56.65	0.08	0.83	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	98.82	17.99	0.44	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	162.92	20.49	0.57	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	181.28	15.42	0.00	0.00	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	299.99	23.01	0.00	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	214.27	17.60	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	264.01	27.58	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	188.04	19.44	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	331.66	49.11	0.72	0.72	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	282.87	27.18	0.80	1.29	1.13
epidermoid carcinoma cell line:A431	10426-106D3	286.90	18.45	1.00	0.33	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	382.31	33.77	0.99	0.66	0.66
epididymis, adult	10197-103E8	268.55	26.16	1.05	0.42	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	217.86	21.82	0.35	1.24	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	53.09	6.29	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	98.55	13.37	0.13	1.05	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	78.05	7.48	0.30	0.49	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	85.70	10.08	0.11	0.22	0.45
esophagus, adult, pool1	10015-101C6	279.14	29.52	0.64	0.21	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	420.17	38.57	2.38	0.50	0.50
eye - muscle inferior rectus, donor1	10272-104E2	275.26	12.07	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	176.75	8.42	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	111.62	14.88	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	186.88	17.20	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	164.69	13.12	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	118.47	19.83	1.02	0.25	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	361.08	43.47	1.41	0.64	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	180.44	17.33	0.24	0.95	0.24
frontal lobe, adult, pool1	10040-101F4	94.57	14.54	0.09	0.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	247.71	21.32	1.20	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	478.40	28.99	0.91	0.00	0.27
gall bladder, adult	10198-103E9	430.72	38.15	1.21	1.21	0.72
gamma delta positive T cells, donor1	11937-126A2	619.53	61.20	0.00	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	469.11	50.79	0.37	0.37	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	285.14	22.18	1.90	1.27	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	122.82	10.83	0.19	0.39	1.16
gastric cancer cell line:AZ521	10549-107H9	75.26	10.98	0.16	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	75.05	15.56	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	136.39	12.34	0.69	0.91	0.23
giant cell carcinoma cell line:LU65	10487-107B1	221.10	14.00	0.80	0.57	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	267.04	34.43	2.66	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	126.70	14.97	0.25	0.75	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	228.52	12.14	0.11	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	203.50	15.59	0.42	0.28	0.42
glioblastoma cell line:T98G	10485-107A8	363.13	24.83	0.22	0.99	0.77
glioma cell line:GI-1	10413-106B8	448.98	36.90	7.03	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	75.81	8.75	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	124.24	28.80	0.00	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	50.66	8.22	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	90.06	5.86	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	474.75	85.65	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	218.57	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	114.98	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	759.35	107.52	0.64	1.60	0.64
hIPS +CCl2, biol_rep1	14383-156B9	110.65	13.31	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	97.85	14.18	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	94.68	11.59	1.29	0.64	0.00
hIPS, biol_rep1	14380-156B6	44.56	15.81	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	85.05	10.29	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	38.62	5.52	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	225.85	40.80	0.29	0.86	1.44
heart - mitral valve, adult	10205-103F7	279.83	31.99	0.60	0.60	1.20
heart - pulmonic valve, adult	10206-103F8	329.46	26.93	0.52	0.78	0.52
heart - tricuspid valve, adult	10207-103F9	406.33	30.81	0.83	0.83	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	198.96	19.18	0.41	1.43	2.04
heart, adult, diseased, donor1	10051-101G6	213.77	19.16	0.43	1.70	4.26
heart, adult, pool1	10016-101C7	247.00	19.78	0.00	0.00	1.15
heart, fetal, pool1	10046-101G1	324.26	39.63	0.21	0.51	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	779.33	75.59	0.31	0.62	2.16
hepatoblastoma cell line:HuH-6	10633-108I3	91.57	14.27	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	190.05	23.98	0.00	0.88	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	201.24	25.85	0.12	1.46	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	194.83	26.48	0.30	1.31	0.91
hepatoma cell line:Li-7	10484-107A7	264.25	16.13	0.44	0.33	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	144.42	14.97	0.00	0.30	0.20
hippocampus - adult, donor10196	10169-103B7	74.76	7.57	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	87.97	16.12	0.20	0.82	0.00
hippocampus, adult, donor10258	10374-105G5	33.86	8.96	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	73.32	4.23	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	101.93	21.97	0.61	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	100.14	21.21	0.00	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	134.06	18.03	0.51	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	111.65	14.66	3.95	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	100.70	21.17	2.07	1.29	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	147.67	15.94	2.28	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	75.32	16.06	1.46	0.88	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	81.22	20.25	1.08	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	90.09	10.43	1.67	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	111.06	13.50	0.71	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	157.66	25.55	1.13	0.64	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	119.85	27.61	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	86.38	18.15	0.94	0.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	79.59	13.76	0.49	0.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	77.68	10.47	0.87	1.75	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	158.46	24.25	0.95	0.95	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	162.66	15.70	1.74	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	110.95	17.49	2.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	76.11	18.46	0.94	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	61.39	18.19	0.91	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	60.45	9.71	0.63	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	172.12	25.64	2.12	0.49	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	169.83	26.71	1.45	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	143.18	21.22	1.20	1.49	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	106.60	21.25	0.74	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	98.71	23.11	1.43	1.43	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	113.51	24.50	0.41	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	171.82	24.29	1.41	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	143.80	26.92	1.90	0.95	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	164.63	17.55	2.12	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	81.19	19.65	1.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	65.75	13.95	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	84.91	12.57	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	194.29	26.33	1.02	1.53	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	105.25	20.45	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	222.81	22.85	1.68	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	94.19	21.49	0.97	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	101.61	12.92	1.34	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	108.29	20.49	0.49	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	174.20	27.81	1.53	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	214.71	22.77	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	156.54	16.88	1.99	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	74.43	22.99	0.55	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	73.46	18.09	0.72	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	67.97	11.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	146.79	20.29	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	239.57	33.72	2.03	0.54	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	171.87	16.70	1.35	0.54	0.00
immature langerhans cells, donor1	11904-125F5	317.94	29.54	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	349.33	24.56	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	104.57	16.94	0.09	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	135.26	7.80	2.93	0.65	0.00
kidney, adult, pool1	10017-101C8	294.57	28.44	1.10	0.40	0.70
kidney, fetal, pool1	10045-101F9	407.51	46.90	0.57	0.57	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	304.92	29.82	0.71	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	87.37	4.42	1.11	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	376.73	50.10	0.55	0.00	1.10
left atrium, adult, donor1	10079-102A7	146.56	20.16	0.54	0.54	1.63
left ventricle, adult, donor1	10078-102A6	135.52	11.12	0.51	0.00	1.52
leiomyoblastoma cell line:G-402	10721-110A1	160.88	18.06	0.27	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	343.08	30.90	3.95	3.59	1.44
leiomyoma cell line:15242A	10570-108B3	333.15	19.57	0.54	3.26	2.72
leiomyoma cell line:15425	10571-108B4	334.60	25.01	1.94	5.10	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	400.01	25.40	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	129.65	8.36	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	117.59	10.27	0.47	0.47	0.24
liposarcoma cell line:KMLS-1	10782-110G8	519.87	45.77	1.87	0.94	1.09
liposarcoma cell line:SW 872	10726-110A6	177.28	19.49	0.61	0.37	0.00
liver, adult, pool1	10018-101C9	216.03	17.02	0.49	0.16	0.32
liver, fetal, pool1	10086-102B5	126.06	13.17	0.00	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	80.06	10.79	0.00	0.15	0.29
locus coeruleus, adult, donor10252	10165-103B3	96.52	17.35	0.00	0.92	0.37
locus coeruleus, adult, donor10258	10375-105G6	34.14	8.46	0.28	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	74.03	10.94	1.26	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	83.73	9.83	0.28	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	177.18	22.06	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	331.78	35.85	1.32	0.66	1.45
lung, adult, pool1	10019-101D1	556.85	73.00	2.24	0.71	1.42
lung, fetal, donor1	10068-101I5	653.87	50.80	2.28	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	339.08	45.36	4.12	0.92	2.29
lymph node, adult, donor1	10077-102A5	275.97	40.24	0.47	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	217.86	39.23	0.88	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	155.45	20.07	0.15	0.45	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	187.74	4.25	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	145.18	35.96	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	183.87	27.60	0.21	0.21	0.00
mature adipocyte, donor3	12233-129G1	117.35	26.08	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	122.66	15.79	0.00	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	141.76	12.63	0.48	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	48.51	12.41	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	86.25	15.63	0.00	0.00	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	29.23	6.04	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	48.19	10.66	0.00	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	58.73	8.94	0.00	0.51	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	96.35	16.13	0.00	0.64	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	3.85	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	49.53	7.18	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	69.44	12.33	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	119.97	19.81	0.15	0.77	0.31
medulla oblongata, adult, pool1	10038-101F2	165.30	24.08	0.00	0.33	0.00
medulla oblongata, newborn, donor10223	10361-105F1	68.39	9.37	0.00	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	33.65	7.75	0.00	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	174.12	20.66	0.24	0.49	0.24
melanoma cell line:COLO 679	10514-107E1	117.44	23.14	1.58	0.00	0.00
melanoma cell line:G-361	10465-106H6	156.36	17.65	6.52	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	443.58	59.16	1.27	1.45	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	135.70	21.15	0.88	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	123.91	21.26	0.00	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	272.19	27.16	1.69	1.07	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	376.10	37.08	1.27	2.18	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	218.65	15.74	0.83	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	216.05	26.83	1.26	0.84	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	192.18	25.03	0.77	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	124.24	14.58	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	126.67	14.25	0.86	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	177.24	24.38	0.92	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	211.69	25.33	0.80	0.66	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	274.13	27.68	1.35	0.81	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	458.94	48.80	1.28	0.85	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	276.00	24.70	2.31	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	485.96	51.06	1.11	0.97	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	289.39	26.18	0.35	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	449.16	48.18	0.82	1.22	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	805.90	85.19	4.31	2.16	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	497.90	57.41	1.03	1.24	1.14
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	615.12	51.53	7.52	1.14	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	584.44	79.30	1.68	1.68	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	591.18	70.39	2.84	1.94	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	403.25	34.66	1.93	2.01	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	420.44	48.97	1.10	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	1025.30	98.15	6.30	4.01	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	644.99	65.68	0.84	4.63	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	385.43	36.53	3.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	400.30	38.62	3.07	0.51	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	448.65	42.40	4.45	2.09	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	437.18	42.52	4.01	1.54	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	392.34	37.66	3.29	2.35	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	435.59	34.86	2.71	1.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	395.33	34.19	3.14	0.39	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	398.97	28.27	3.71	0.46	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	386.43	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	469.83	42.69	5.48	2.31	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	441.29	37.70	3.12	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	451.38	45.91	1.92	1.92	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	382.06	42.53	1.47	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	372.58	37.59	2.01	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	420.84	35.21	5.32	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	452.75	47.68	6.01	1.72	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	432.04	51.95	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	464.85	25.82	0.00	5.16	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	406.31	36.70	0.97	1.30	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	401.58	29.10	4.36	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	373.69	31.45	1.07	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	363.09	23.72	1.64	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	357.23	32.65	0.78	0.39	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	346.29	18.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	373.54	33.78	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	438.58	14.30	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	394.91	29.65	1.78	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	371.63	25.59	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	243.47	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	379.40	32.30	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	158.31	7.93	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	182.68	8.60	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	127.74	3.99	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	59.90	4.48	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	46.87	3.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	35.37	7.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	39.90	8.42	0.94	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	46.78	9.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	65.05	9.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	69.34	5.14	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	76.41	18.59	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	44.53	9.40	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	31.40	5.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	54.70	12.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	50.37	10.07	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	8.72	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	46.88	8.87	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	63.12	5.46	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	43.66	7.41	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	69.25	9.52	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	66.52	13.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	70.29	15.28	1.02	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	601.95	78.15	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	611.63	66.15	0.71	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	412.15	25.95	1.16	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	423.09	4.27	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	208.27	16.85	0.92	1.34	1.23
mesothelioma cell line:Mero-25	10850-111F4	1228.27	116.43	4.09	9.53	4.09
mesothelioma cell line:Mero-41	10851-111F5	635.15	39.36	1.47	6.60	2.69
mesothelioma cell line:Mero-48a	10852-111F6	560.44	43.84	0.66	2.21	2.66
mesothelioma cell line:Mero-82	10853-111F7	472.52	35.22	1.31	2.37	3.42
mesothelioma cell line:Mero-83	10854-111F8	362.74	33.87	2.89	3.57	1.19
mesothelioma cell line:Mero-84	10855-111F9	124.62	12.64	0.25	1.26	0.51
mesothelioma cell line:Mero-95	10856-111G1	181.16	17.60	2.28	0.62	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	446.75	32.14	1.16	2.65	0.83
mesothelioma cell line:NCI-H226	10846-111E9	304.97	17.92	0.72	2.71	2.35
mesothelioma cell line:NCI-H2452	10848-111F2	203.62	17.77	1.37	1.37	0.68
mesothelioma cell line:NCI-H28	10845-111E8	286.78	21.12	1.02	1.78	0.51
mesothelioma cell line:No36	10857-111G2	100.80	7.50	1.96	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	234.92	11.11	0.54	0.54	1.63
migratory langerhans cells, donor1	11901-125F2	492.28	55.27	2.69	0.58	1.15
migratory langerhans cells, donor2	11902-125F3	560.63	57.03	1.59	0.49	0.73
migratory langerhans cells, donor3	11903-125F4	424.47	64.79	1.08	0.90	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	379.70	38.52	1.96	4.24	5.22
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	218.72	19.50	0.64	1.27	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	306.61	26.49	0.23	0.00	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	399.23	52.71	1.71	1.14	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	257.79	35.48	0.18	0.37	0.18
myeloma cell line:PCM6	10474-106I6	117.61	24.12	0.59	0.40	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	519.46	61.38	0.00	1.01	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	182.02	22.16	0.39	0.78	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	266.75	35.43	0.45	0.22	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	234.08	26.62	0.44	0.22	0.37
nasal epithelial cells, donor2	12227-129F4	432.76	51.89	0.55	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	20.25	3.68	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	102.15	26.00	0.00	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	45.34	17.29	0.00	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	48.08	10.44	0.00	0.37	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.63	6.88	0.24	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	106.27	22.49	0.32	0.79	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	85.33	14.89	0.20	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	52.77	12.72	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	791.85	73.20	0.27	0.80	1.06
neutrophil PMN, donor1	12133-128D9	1323.86	252.87	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	810.12	132.81	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	899.71	161.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	217.83	27.40	0.17	0.34	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	117.67	12.81	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	270.27	26.61	1.28	0.00	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	747.30	40.73	5.26	4.73	1.58
nucleus accumbens, adult, pool1	10037-101F1	100.58	14.72	0.00	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	57.69	6.18	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	131.23	23.88	0.54	0.81	0.54
occipital cortex, newborn, donor10223	10355-105E4	68.79	10.19	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	52.74	9.71	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	26.60	6.87	0.43	0.00	0.43
occipital pole, adult, pool1	10036-101E9	87.20	15.30	0.00	0.08	0.00
olfactory region, adult	10195-103E6	55.98	12.04	0.00	0.19	0.38
optic nerve, donor1	10277-104E7	132.07	14.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	289.33	19.36	4.67	0.57	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	152.09	13.05	0.14	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	279.89	25.23	1.86	1.69	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	169.91	17.56	0.69	1.62	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	754.61	57.62	2.65	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	316.74	20.56	0.00	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	299.00	20.36	2.33	0.00	0.85
ovary, adult, pool1	10020-101D2	331.94	49.35	1.05	0.61	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	711.83	94.59	0.92	1.65	1.83
pancreas, adult, donor1	10049-101G4	207.88	23.52	0.00	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	183.93	19.85	2.24	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	378.18	21.46	1.19	3.58	2.21
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	323.05	28.31	1.49	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	93.81	14.83	0.18	0.09	0.09
parietal cortex, adult, donor10258	10373-105G4	77.07	11.01	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	49.85	13.17	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	88.08	14.25	0.00	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	112.18	19.12	0.09	0.26	0.00
parietal lobe, fetal, donor1	10072-101I9	41.70	14.55	0.00	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	50.47	5.23	0.37	0.00	0.00
parotid gland, adult	10199-103F1	402.06	22.82	0.00	1.85	3.08
penis, adult	10200-103F2	317.97	38.67	1.07	3.22	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	156.19	14.13	0.37	1.30	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	210.82	21.27	1.17	0.44	0.58
pineal gland - adult, donor10196	10179-103C8	72.24	10.32	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	82.32	13.03	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	38.88	1.88	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	82.97	14.17	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	105.28	19.28	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	29.79	3.40	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	383.14	43.22	0.75	0.65	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	88.86	19.47	0.13	0.26	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	630.03	42.65	0.93	0.62	0.78
pons, adult, pool1	10033-101E6	88.91	14.72	0.09	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	91.36	14.99	0.09	0.26	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	261.42	56.47	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	22.03	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	214.56	25.49	0.29	0.58	0.44
prostate cancer cell line:PC-3	10439-106E7	199.29	26.50	0.36	0.91	0.36
prostate, adult, pool1	10022-101D4	305.36	37.73	1.54	0.09	0.18
putamen, adult, donor10196	10176-103C5	50.28	13.46	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	70.59	13.73	0.00	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	42.62	8.74	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	51.22	6.04	0.00	0.00	0.24
putamen, newborn, donor10223	10365-105F5	40.48	4.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	94.26	12.22	0.00	0.00	1.16
rectum, fetal, donor1	10067-101I4	267.07	45.90	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	576.00	41.98	1.48	2.54	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	115.15	11.18	0.00	1.24	0.00
retina, adult, pool1	10030-101E3	261.92	29.42	0.10	0.40	0.30
retinoblastoma cell line:Y79	10475-106I7	40.27	12.47	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	51.64	8.85	0.12	0.00	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	36.27	12.94	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	346.34	37.13	0.00	0.00	1.52
salivary acinar cells, donor1	11771-123I7	200.38	14.41	1.78	0.49	0.81
salivary acinar cells, donor2	11772-123I8	248.80	17.35	2.20	0.96	1.10
salivary acinar cells, donor3	11773-123I9	168.16	12.58	0.00	0.66	1.99
salivary gland, adult, pool1	10093-102C3	546.21	40.61	0.57	2.86	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	130.94	12.06	0.51	0.34	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	99.68	14.22	0.71	0.12	0.24
seminal vesicle, adult	10201-103F3	183.59	17.99	2.12	2.65	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	401.31	38.38	0.97	1.21	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	193.76	15.35	0.50	0.25	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	329.16	16.06	2.01	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	485.43	50.77	0.81	2.01	2.01
signet ring carcinoma cell line:Kato III	10436-106E4	268.69	11.61	0.88	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	143.09	11.74	0.52	0.13	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	165.98	19.86	0.71	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	224.64	28.19	0.36	0.12	0.48
skeletal muscle, fetal, donor1	10066-101I3	100.50	14.07	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	162.85	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	214.62	33.46	1.26	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	126.41	20.01	0.00	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	70.61	10.72	0.32	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	27.56	14.65	0.00	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	118.18	13.52	0.33	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	27.83	5.47	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	207.89	25.06	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	412.32	24.96	2.63	0.72	0.36
small intestine, fetal, donor1	10064-101I1	169.28	26.29	0.25	1.72	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	268.25	10.26	1.03	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	251.22	31.79	0.26	1.29	1.55
somatostatinoma cell line:QGP-1	10781-110G7	107.21	8.31	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	79.83	9.86	0.00	0.23	0.46
spinal cord, adult, donor10252	10159-103A6	113.94	21.68	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	39.43	7.61	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	118.92	27.44	1.22	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	85.41	10.10	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	700.47	59.44	1.05	1.34	1.19
spleen, adult, pool1	10025-101D7	553.75	60.90	1.87	0.55	0.66
spleen, fetal, pool1	10044-101F8	626.50	84.22	0.72	0.40	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	160.65	28.16	0.52	0.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	98.36	7.41	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	225.05	19.92	1.05	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	313.53	22.28	0.00	0.39	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	182.46	13.96	0.45	0.56	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	77.52	8.90	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	253.42	25.38	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	208.25	37.38	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	383.96	29.05	1.71	2.28	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	113.41	20.98	0.00	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	38.79	5.17	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	67.83	6.36	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	87.58	25.22	0.23	0.23	0.92
temporal lobe, adult, pool1	10031-101E4	101.89	18.90	0.08	0.42	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	28.49	14.96	0.00	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	50.55	10.55	0.44	0.88	0.00
tenocyte, donor1	11763-123H8	217.84	27.23	0.00	1.05	3.14
tenocyte, donor2	11765-123I1	118.65	14.12	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	189.78	20.02	0.74	2.59	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	137.84	27.02	0.17	0.51	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	86.63	16.34	0.62	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	13.33	2.17	0.00	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	167.82	26.28	2.54	0.38	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	103.24	20.04	0.76	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	73.29	11.23	0.55	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	60.91	16.61	0.33	0.65	0.65
testis, adult, pool1	10026-101D8	266.28	32.00	1.29	0.64	0.64
testis, adult, pool2	10096-102C6	116.83	22.55	1.35	1.80	0.00
thalamus - adult, donor10196	10168-103B6	69.55	5.52	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	93.77	19.38	0.00	0.63	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	12.32	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	32.11	6.09	0.00	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	21.86	3.45	0.00	0.00	0.00
throat, adult	10209-103G2	240.18	19.72	0.50	1.00	0.00
throat, fetal, donor1	10061-101H7	155.70	27.42	0.30	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	80.29	15.10	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	501.35	69.79	4.87	0.60	0.40
thymus, fetal, pool1	10043-101F7	536.04	61.41	1.14	0.62	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	141.07	10.11	0.66	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	505.96	58.81	0.84	1.40	0.70
thyroid, adult, pool1	10028-101E1	306.16	32.19	0.75	0.84	0.47
thyroid, fetal, donor1	10060-101H6	190.36	29.79	0.00	0.26	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	307.96	21.56	0.00	0.00	0.00
tongue, adult	10203-103F5	221.65	15.82	0.23	2.33	0.70
tongue, fetal, donor1	10059-101H5	114.29	20.89	0.39	0.39	0.39
tonsil, adult, pool1	10047-101G2	508.99	46.78	0.60	0.50	0.70
trachea, adult, pool1	10029-101E2	324.74	32.47	0.74	0.33	0.16
trachea, fetal, donor1	10058-101H4	166.96	28.85	1.15	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	338.69	21.97	1.77	0.71	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	314.18	24.42	0.30	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	266.52	41.52	4.39	0.94	0.78
tridermal teratoma cell line:HGRT	10694-109G1	338.65	41.86	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	112.08	10.41	0.68	0.68	0.25
umbilical cord, fetal, donor1	10057-101H3	206.56	25.04	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	1000.73	82.07	1.88	1.37	0.34
uterus, fetal, donor1	10055-101H1	210.91	38.39	0.00	0.51	1.02
vagina, adult	10204-103F6	306.94	23.26	1.29	0.65	0.00
vein, adult	10191-103E2	432.92	50.42	0.66	0.88	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	175.71	35.25	0.53	0.53	1.34